Sign in
8-K

Current Report

Keros Therapeutics, Inc. Filed Acc 0001664710-21-000040

Shareholder vote results

  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading keros-form8xk2021shmeeting.htm…